Atara Biotherapeutics Inc

-0.15 (-8.48%)
7:57:12 PM EDT: $1.65 +0.03 (+1.85%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)158.71M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$5.36 Million
Adjusted EPS-$0.64
See more estimates
10-Day MA$1.97
50-Day MA$2.60
200-Day MA$3.77
See more pivots

Atara Biotherapeutics Inc Stock, NASDAQ:ATRA

2380 Conejo Spectrum Street, Suite 200, Thousand Oaks, California 91320
United States of America
Phone: +1.805.623.4211
Number of Employees: 334


Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.